Mimi is passionate about bringing innovation to the world’s most vulnerable communities to reduce global health inequities. As the CEO and co-founder of the early-stage biotech startup PhagePro, she has focused on reducing antimicrobial resistance in resource-limited settings.

Mimi graduated from MIT in 2011 and earned her PhD from Tufts. After her Ph.D., Mimi pursued a Master's in Public Health at Boston University. She has also served as the U.S. representative in the Young Leaders Circle for three years as a part of American Society of Microbiology’s initiative to address the needs of international early-stage scientists. Currently, she serves as the U.S. One Young World Delegate to elevate the voices of healthcare workers around the world.

For her work with PhagePro, Mimi has been awarded multiple honors and fellowships including MIT Technology Review 35 Innovators Under 35, Massachusetts Next Generation Initiative, The Capital Network Female Founder Fellowship, and the Henri Termeer Legacy Program.